HRAS and breast cancer: Among the recurrently amplified and deleted loci, we noted that canonical oncogenes, such as EGFR and HRAS, were recurrently amplified in CMTs; however, amplification of ERBB2 and MYC, which is common in human breast cancers, was not reflected in the GISTIC peaks of CMTs.